Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|June 2, 2015
Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized TrialHarold Bays, Daniel Gaudet, Robert Weiss, et al.
The American Journal of Gastroenterology|January 26, 2002
The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy studyFrank Lanza, Bruce Sahba, Howard Schwartz, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|November 28, 2022
Mesenteric fat cryolipolysis attenuates insulin resistance in the Ossabaw swine model of the metabolic syndromeRafi Mazor, Alex Babkin, Peter J Littrup, et al.
Journal of the American College of Cardiology|April 3, 2014
Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumabMichael J Koren, Pernille Lundqvist, Michael Bolognese, et al.
Journal of Clinical Lipidology|December 3, 2010
Safety of extended-release niacin/laropiprant in patients with dyslipidemiaJames McKenney, Harold Bays, Michael Koren, et al.
Obesity (Silver Spring, Md.)|April 12, 2007
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight lossNgozi Erondu, Thomas Wadden, Ira Gantz, et al.
The New England Journal of Medicine|October 30, 2024
Once-Weekly Semaglutide in Persons with Obesity and Knee OsteoarthritisHenning Bliddal, Harold Bays, Sébastien Czernichow, et al.
European Journal of Preventive Cardiology|August 25, 2022
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity FederationFrancisco Lopez-Jimenez, Wael Almahmeed, Harold Bays, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|April 7, 2016
Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)Harold Bays, Shanu N Kothari, Dan E Azagury, et al.
Pageof 8